New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

O relatório

Notícias verificadas sobre financiamento, sedes e liderança das empresas mais inovadoras do mundo

77 relatórios e mais

Atualizado diariamente com as últimas inteligências de mercado
Fundraising
Advanced NanoTherapies

Advanced NanoTherapies Raises Over $31M Series B for Dual-Drug Vascular Balloons

Advanced NanoTherapies announced the closing of an oversubscribed Series B financing of more than $31 million, co-led by S3 Ventures and an undisclosed strategic investor.

SalesTools Research
Jun 2, 2026
2 min read•$31M+
Fundraising
Rakuten Medical

Rakuten Medical Raises $100M Series F | Photoimmunotherapy Cancer Treatment

Cancer treatment company Rakuten Medical secures $100 million Series F led by TaiAx for Phase 3 trials.

SalesTools Research
Jan 8, 2026
0 min read•$100M
Fundraising
Corsera Health

Corsera Health Raises $80M Series A | Once-Yearly Cardiovascular RNAi

Biotech startup Corsera Health secures $80 million Series A for once-yearly RNAi cardiovascular treatments.

SalesTools Research
Jan 10, 2026
0 min read•$80M
MedTech
NeuroLink Brain

NeuroLink Brain Raises $580M Series D to Transform Healthcare

NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.

Editorial Team
Sep 9, 2025
0 min read•$580M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
Jan 11, 2026
0 min read•$200M
HealthTech
Evommune

Evommune raises $50M Series B at $300M valuation

Evommune raises $50M in Series B at $300M valuation. Oral immunology treatments...

Editorial Team
Aug 1, 2025
0 min read•$50M
HealthTech
NRG Therapeutics

NRG Therapeutics raises $67M Series B

NRG Therapeutics raises $67M in Series B. Developing treatments for ALS and neurodegenerative diseases...

Editorial Team
Sep 8, 2025
0 min read•$67M
HealthTech
Kardigan

Kardigan raises $300M Series A

Kardigan raises $300M in Series A. Healthcare company developing innovative treatments for cardiometabolic diseases...

Editorial Team
Sep 24, 2025
0 min read•$300M
Biotech
Seaport Therapeutics

Seaport Therapeutics raises $225M Series C at $1.2B valuation

Seaport Therapeutics raises $225M in Series C at $1.2B valuation. Neuropsychiatric disease treatments...

Editorial Team
Sep 12, 2024
0 min read•$225M
Página 1

Mostrando 9 relatórios • Página 1 • Categoria: all

Fique à frente do mercado

Receba insights semanais em sua caixa de entrada. Sem spam, apenas inteligência.